Recommendations/Statements

  • Statement of the DOG, the RG, and the BVA on the therapeutic use of voretigene neparvovec (Luxturna TM) in ophthalmology (January 2019)
    PDF
    Springer Link
  • Recommendations by the DOG for the planning of clinical trials on behalf of third parties (March 2018)
    PDF
    Springer Link
  • Statement of the Professional Association of German Ophthalmologists (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy (January 2018) PDF
    Springer Link
  • Statement of the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular Degeneration (October 2017)
    PDF
    Springer Link
  • Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular Degeneration (AMD) (August 2017, update October 2018)
    PDF
    Springer Link